HepaClear, A Blood-Based Panel Combining Novel Methylated CpG Sites and Protein Markers, for the Detection of Early-Stage Hepatocellular Carcinoma

MLA

Yi Bai, et al. “HepaClear, A Blood-Based Panel Combining Novel Methylated CpG Sites and Protein Markers, for the Detection of Early-Stage Hepatocellular Carcinoma.” SSRN Electronic Journal, Jan. 2022. EBSCOhost, https://doi.org/10.2139/ssrn.4286194.

APA

Yi Bai, Juan Xu, Deqiang Li, Xiaoyu Zhang, Dapeng Chen, Fucun Xie, Longmei Huang, Xiao-Tian Yu, Haitao Zhao, & Yamin Zhang. (2022). HepaClear, A Blood-Based Panel Combining Novel Methylated CpG Sites and Protein Markers, for the Detection of Early-Stage Hepatocellular Carcinoma. SSRN Electronic Journal. https://doi.org/10.2139/ssrn.4286194

Chicago

Yi Bai, Juan Xu, Deqiang Li, Xiaoyu Zhang, Dapeng Chen, Fucun Xie, Longmei Huang, Xiao-Tian Yu, Haitao Zhao, and Yamin Zhang. 2022. “HepaClear, A Blood-Based Panel Combining Novel Methylated CpG Sites and Protein Markers, for the Detection of Early-Stage Hepatocellular Carcinoma.” SSRN Electronic Journal, January. doi:10.2139/ssrn.4286194.